A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

Study ID
NCT02539537

Study type
Interventional

Study phase
Phase 3

Study status
Completed

Trial Acronym

NEOPAN

Trial Summary

French national multicentric phase III trial evaluating chemotherapy with Folfirinox or gemcitabine in locally advanced pancreatic carcinoma.

More informations

Trial Starting Date

Oct 23,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

171